For patients, costly hepatitis C cure is priceless By: CNBC.com News May 23, 2014 at 09:33 AM EDT As debate rages over costly drugs like Gilead's Solvadi, patients caution: Treatment is priceless. Read More >> Related Stocks: Express Scripts Holding Gilead Sciences Johnson & Johnson